100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Summary Vaccine technologies and applications - H5: attenuated vaccines $7.73   Add to cart

Summary

Summary Vaccine technologies and applications - H5: attenuated vaccines

 7 views  0 purchase
  • Course
  • Institution

A detailed, complete, English-language summary of chapter 5, attenuated vaccines. Indicate what is important for the exam.

Preview 2 out of 15  pages

  • July 2, 2024
  • 15
  • 2023/2024
  • Summary
avatar-seller
VACCINE TECHNOLOGY: ATTENUATED
VACCINES
1: LIVE VACCINES

- Live vaccines = consist of viruses/bacteria that replicate to a limited degree in the host
o Resembling that of the natural microorganism
o Eliciting an IR similar to that elicited by the natural infection = GOOD!
- Attenuation: disease-causing capacity reduced by biological/technical manipulations
o Attenuation needs to be balanced!
 Overattenuated: no longer infectious enough to function as vaccine, no IR
will be induced
 Underattenuated: retaining pathogenicity even to a limited extend (chance
of disease)
o Sometimes attenuation does not work  if the pathogen is already causing a weak
IR!
- Live vaccines usually elicit:
o Humoral immunity  Abs
o Cellular immunity  cytotoxic T-lymphocytes (CTLs)
o = strong!!
- Some live vaccines are close to ideal in their capability to elicit life-long protection, in just 1-2
doses, with minimal reactogenicity
- Live vaccines may be feasible in cases in which the natural infection/disease confers life-
long protection in the host
o So if life-long protection is possible after natural infection, it is possible to make live
vaccines: when a natural infection does not give good protection by itself  no
suitable for making attenuated vaccines!

IMPORTANT TABLE: EXAM!

Live vaccines

MMR vaccines = Live-attenuated
vaccines that protect against
measles, mumps, rubella, (MMRV:
and varicella (chickenpox), only for
children who are 12 months
through 12 years of age).

Inactivated vaccines




1

,  For live vaccines, safety is uncertain before large-scale use  that is why post-market
surveillance is that important!

Nucleic acid-based vaccines




2: ATTENUATED VACCINES

2.1: WHEN IS DEVELOPING A LIVE, ATTENUATED VACCINE A GOOD OPTION?

- Strategic choice of developing live – inactivated – or nucleic-acid-based vaccine should take
into account:
o Pathogenesis – epidemiology – immunobiology of the target infection or disease
o Technical feasibility of alternative vaccine designs
- Epidemiology = target population for the vaccine
o Age + state of health of this population can favor certain designs as more appropriate
to elicit protective immunity
o A vaccine intended for healthy subjects (especially infants): minimizing acute
reactogenicity is CRITICALLY IMPORTANT as is minimizing the risk for chronic
autoimmune disease development in genetically susceptible subjects
 The people are healthy, we want to keep it that way!
 Don’t give live attenuated to an immunocompromised person!

2.2: WHEN IS LIVE-ATTENUATED VACCINE NOT A GOOD OPTION?

Live vaccines: not technically feasible for most vaccines currently under development
 balance between over- and underattenuation is delicate and, for some viruses/bacteria,
technically unachievable right now

o Because a live vaccine can replicate  is possible to revert to more natural,
pathogenic state
o Some live vaccines can be transmitted from a vaccinated to non-immunized person
 Serious if the recipient has an immune deficiency! Live vaccines = not safe to
be used in immune deficient people
 Allows for higher risk of reversal to virulence and cause of disease
- MAJOR ISSUE = SAFETY: adverse effects that happen in 1/10 000 people only becomes visible
in post-marketing surveillance!




2

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller s0192734. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $7.73. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

67474 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$7.73
  • (0)
  Add to cart